Bavarian Nordic partners up with Dynavax on hepatitis B vaccine
The two firms expect to launch the new vaccine in Germany in Q4 2021.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Danish pharmaceutical company Bavarian Nordic is entering into a marketing and distribution agreement with Dynavac for the launch of a new hepatitis B vaccine in Germany, according to a press release published on Thursday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bavarian Nordic maintains guidance for 2021
For subscribers
